About Matthew Chang
Matthew Chang is a director at Immunomic Therapeutics.
Matthew Chang first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Matthew Chang in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthew Chang works with at each company, as listed on that company's latest Form D.
Immunomic Therapeutics, Inc. · Form D, Jun 2, 2025
YJ
Yang Gon Jin
Director
SP
Steve Park
Director
RA
Robert Ahlgren
Director
DK
Dong-Gun Kim
Executive officer and director
JW
James Wishart
Director
KA
Ki-Hong Ahn
Director